PCN79 Cost Effectiveness of Erlotinib in First Line Treatment of Advanced Non Small Cell Lung Cancer (NSCLC) in Vulnerable Elderly Patients: An Economical Analysis of a prospective Phase 2 Study (GFPC 0505)
Chouaid, C., Le Caer, H., Corre, R., Crequit, J., Jullian, H., Falchero, L., Dujon, C., Vergnenegre, A.Volume:
14
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2011.08.1180
Date:
November, 2011
File:
PDF, 63 KB
english, 2011
File converter
More search results
More benefits 
